Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Metabolic Syndrome Independently Predicts Vascular Complications in Diabetes

  • 작성자한진
  • 작성일2007-01-11 01:04:13
  • 조회수1919
  • 첨부파일첨부파일
By Martha Kerr NEW YORK (Reuters Health) Dec 27 - The metabolic syndrome is an independent clinical indicator of micro- or macrovascular complications in diabetes, according to a report in the December issue of Diabetes Care. The syndrome may even be involved in the pathogenesis of vascular complications. The Metascreen Writing Committee, headed by Dr. Bonnadonna Riccardo of Ospedale Civile Maggiore in Verona, Italy, analyzed the effect of the metabolic syndrome on vascular complications in 8,497 patients. Of these, 7,859 had type 2 diabetes and 638 had type 1 diabetes. The Committee analyzed the link according to two different definitions: that of the National Heart, Lung, and Blood Institute/American Heart Association (NHLBI/AHA) and definition accepted by the International Diabetes Federation (IDF). The diagnostic criteria for the NHLBI/AHA definition are abdominal obesity, atherogenic dyslipidemia, elevated blood pressure and elevated blood glucose. The IDF definition consists of abdominal obesity, using a lower diagnostic threshold, and somewhat more ambiguous indicators of cardiovascular risk. "Either definition of the metabolic syndrome was an independent statistical indicator" of nephropathy and neuropathy in type 1 diabetes and of all types of cardiovascular complications, including retinopathy, in type 2 diabetes, the investigators report. "This study is cross-sectional; hence, it provides evidence that the metabolic syndrome is only a risk indicator of concomitant specific and non-specific complications in both types of diabetes," Dr. Riccardo told Reuters Health. "However, from all we know, the presence of the entity we call today 'metabolic syndrome' in a patient with diabetes conveys a higher risk of developing diabetic complications over time." The various definitions of metabolic syndrome cause confusion and "are somewhat wanting," Dr. Riccardo said. "Further studies will be needed to refine them and to give stronger and wider support to their clinical applicability and use." "The findings of the present study are actually in favor of the clinical usefulness of the 'metabolic syndrome' as currently defined. Indeed, in this study the dichotomous categorization metabolic syndrome yes/no is as effective as the component parts of the syndrome in marking the presence of diabetic complications," the Italian investigator said. Diabetes Care 2006;29:2701-2707.
Total402 [ page1/27 ]
No. 제목 작성자 작성일 조회수
402 2022학년도 인제학술상 수상자 선정 결과 2023.01.05 관리자 2023.01.05 38
401 안전관리 우수연구실 인증 취득 2023.01.05 관리자 2023.01.05 26
400 한진교수 화의자의학상 수상 2023.01.05 관리자 2023.01.05 35
399 이온통로 학회 -Amy 포스터상 수상 2019.01.15 김형규 2019.01.15 2,577
398 센터 겸임교수 조성우 교수 - 한빛사 -JACC Vascular Imaging 2018.12.08 김형규 2018.12.08 2,718
397 2017 IMPACT Symposium 개최 첨부파일 2017.10.31 김보현 2017.10.31 2,579
396 경암바이오유스 2017 첨부파일 2017.08.11 김보현 2017.08.11 2,862
395 KORUS 2017 첨부파일 2017.06.21 김보현 2017.06.21 2,977
394 IMPACT 2016 심포지엄 개최 안내 첨부파일 2016.04.18 관리자 2016.04.18 3,984
393 IMPACT 2015 심포지엄 개최 안내 첨부파일 2015.04.20 서대윤 2015.04.20 2,864
392 2015 중점연구소 성과 전시회 첨부파일 2015.03.31 김형규 2015.03.31 2,455
391 Best Miso Award - 한진 2014.11.04 이정훈 2014.11.04 2,064
390 신진생리학자상 - 김형규 2014.10.29 이정훈 2014.10.29 1,808
389 대한생리학회 KJPP 인용상 - 김형규, 정승훈 2014.10.29 이정훈 2014.10.29 1,767
388 Best Presentation Award - 김형규 2014.09.29 이정훈 2014.09.29 1,002
처음이전1 2 3 4 5 6 7 8 9 10 다음 마지막